{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:53:27Z","timestamp":1774932807096,"version":"3.50.1"},"reference-count":56,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"unspecified","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018806","name":"Science and Technology Department of Hubei Province","doi-asserted-by":"crossref","award":["2020FCA024"],"award-info":[{"award-number":["2020FCA024"]}],"id":[{"id":"10.13039\/501100018806","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,6,25]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The rapid worldwide spread of COVID-19 has caused a global health crisis. To date, symptomatic supportive care has been the most common treatment. It has been reported that the mechanism of COVID-19 is related to cytokine storms and subsequent immunogenic damage, especially damage to the endothelium and alveolar membrane. Vitamin C (VC), also known as L-ascorbic acid, has been shown to have antimicrobial and immunomodulatory properties. A high dose of intravenous VC (HIVC) was proven to block several key components of cytokine storms, and HIVC showed safety and varying degrees of efficacy in clinical trials conducted on patients with bacterial-induced sepsis and acute respiratory distress syndrome (ARDS). Therefore, we hypothesise that HIVC could be added to the treatment of ARDS and multiorgan dysfunction related to COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>The investigators designed a multicentre prospective randomised placebo-controlled trial that is planned to recruit 308 adults diagnosed with COVID-19 and transferred into the intensive care unit. Participants will randomly receive HIVC diluted in sterile water or placebo for 7 days once enrolled. Patients with a history of VC allergy, end-stage pulmonary disease, advanced malignancy or glucose-6-phosphate dehydrogenase deficiency will be excluded. The primary outcome is ventilation-free days within 28 observational days. This is one of the first clinical trials applying HIVC to treat COVID-19, and it will provide credible efficacy and safety data. We predict that HIVC could suppress cytokine storms caused by COVID-19, help improve pulmonary function and reduce the risk of ARDS of COVID-19.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The study protocol was approved by the Ethics Committee of Zhongnan Hospital of Wuhan University (identifiers: Clinical Ethical Approval No. 2020001). Findings of the trial will be disseminated through peer-reviewed journals and scientific conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"clintrialgov\" specific-use=\"clinicaltrial pre-results\" xlink:href=\"NCT04264533\">NCT04264533<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2020-039519","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:17:43Z","timestamp":1594261063000},"page":"e039519","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":99,"title":["Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomised controlled trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct04264533","registry":"10.18810\/clinical-trials-gov","type":"preResults"},{"clinical-trial-number":"nct04264533","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Fang","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0849-5648","authenticated-orcid":false,"given":"Zhiyong","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2025121508165668000_10.7.e039519.1","unstructured":"Coronavirus disease 2019 (COVID-19) situation report \u2013 153: World Health organization, 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports [Accessed 22 June 2020]."},{"key":"2025121508165668000_10.7.e039519.2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"The Lancet"},{"key":"2025121508165668000_10.7.e039519.3","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2025121508165668000_10.7.e039519.4","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101623","article-title":"Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis","volume":"34","author":"Rodriguez-Morales","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2025121508165668000_10.7.e039519.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31022-9"},{"key":"2025121508165668000_10.7.e039519.6","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19","volume":"382","author":"Geleris","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121508165668000_10.7.e039519.7","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"2025121508165668000_10.7.e039519.8","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0343-9"},{"key":"2025121508165668000_10.7.e039519.9","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-017-0629-x"},{"key":"2025121508165668000_10.7.e039519.10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21072657","article-title":"A review of SARS-CoV-2 and the ongoing clinical trials","volume":"21","author":"Tu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2025121508165668000_10.7.e039519.11","doi-asserted-by":"crossref","unstructured":"Wan S , Yi Q , Fan S , et al . Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCp). medRxiv 2020 2020.","DOI":"10.1101\/2020.02.10.20021832"},{"key":"2025121508165668000_10.7.e039519.12","doi-asserted-by":"crossref","unstructured":"Zhou Y , Fu B , Zheng X , et al . Aberrant pathogenic GM-CSF+ T cells and inflammatory CD14+ CD16+ monocytes in severe pulmonary syndrome patients of a new coronavirus. bioRxiv 2020.","DOI":"10.1101\/2020.02.12.945576"},{"key":"2025121508165668000_10.7.e039519.13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2025121508165668000_10.7.e039519.14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1556\/1886.2019.00016","article-title":"Immunomodulatory and antimicrobial effects of vitamin C","volume":"9","author":"Mousavi","year":"2019","journal-title":"Eur J Microbiol Immunol"},{"key":"2025121508165668000_10.7.e039519.15","doi-asserted-by":"crossref","DOI":"10.3390\/nu11040708","article-title":"Vitamin C can shorten the length of stay in the ICU: a meta-analysis","volume":"11","author":"Hemil\u00e4","year":"2019","journal-title":"Nutrients"},{"key":"2025121508165668000_10.7.e039519.16","unstructured":"Sauberlich HE , Packer L , Fuchs J . A history of scurvy and vitamin C. Vitamin C in Health & Disease, 1997."},{"key":"2025121508165668000_10.7.e039519.17","doi-asserted-by":"crossref","DOI":"10.3390\/nu9111211","article-title":"Vitamin C and immune function","volume":"9","author":"Carr","year":"2017","journal-title":"Nutrients"},{"key":"2025121508165668000_10.7.e039519.18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1093\/jn\/137.7.1757","article-title":"Plasma vitamin C is inversely related to body mass index and waist circumference but not to plasma adiponectin in nonsmoking adults","volume":"137","author":"Johnston","year":"2007","journal-title":"J Nutr"},{"key":"2025121508165668000_10.7.e039519.19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1743-7075-3-35","article-title":"Marginal vitamin C status is associated with reduced fat oxidation during submaximal exercise in young adults","volume":"3","author":"Johnston","year":"2006","journal-title":"Nutr Metab"},{"key":"2025121508165668000_10.7.e039519.20","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1096\/fasebj.10.7.8635688","article-title":"Antioxidant and redox regulation of gene transcription","volume":"10","author":"Sen","year":"1996","journal-title":"Faseb J"},{"key":"2025121508165668000_10.7.e039519.21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2004.02.004"},{"key":"2025121508165668000_10.7.e039519.22","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/426740","article-title":"Vitamin C mitigates oxidative stress and tumor necrosis factor-alpha in severe community-acquired pneumonia and LPS-induced macrophages","volume":"2014","author":"Chen","year":"2014","journal-title":"Mediators Inflamm"},{"key":"2025121508165668000_10.7.e039519.23","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.9.3205"},{"key":"2025121508165668000_10.7.e039519.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.imbio.2008.09.003"},{"key":"2025121508165668000_10.7.e039519.25","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4024672","article-title":"The parenteral vitamin C improves sepsis and sepsis-induced multiple organ dysfunction syndrome via preventing cellular immunosuppression","volume":"2017","author":"Gao","year":"2017","journal-title":"Mediators Inflamm"},{"key":"2025121508165668000_10.7.e039519.26","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1254\/jjp.66.451","article-title":"Enhancement by ascorbic acid 2-glucoside or repeated additions of ascorbate of mitogen-induced IgM and IgG productions by human peripheral blood lymphocytes","volume":"66","author":"Tanaka","year":"1994","journal-title":"Jpn J Pharmacol"},{"key":"2025121508165668000_10.7.e039519.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcyt.2015.01.004"},{"key":"2025121508165668000_10.7.e039519.28","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0161OC"},{"key":"2025121508165668000_10.7.e039519.29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.arcmed.2020.04.019","article-title":"Oxidative stress as key player in severe acute respiratory syndrome coronavirus (SARS-CoV) infection","volume":"51","author":"Delgado-Roche","year":"2020","journal-title":"Arch Med Res"},{"key":"2025121508165668000_10.7.e039519.30","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.chemosphere.2015.09.023","article-title":"Amelioration of particulate matter-induced oxidative damage by vitamin C and quercetin in human bronchial epithelial cells","volume":"144","author":"Jin","year":"2016","journal-title":"Chemosphere"},{"key":"2025121508165668000_10.7.e039519.31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.122.6_suppl.314S"},{"key":"2025121508165668000_10.7.e039519.32","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00300.2011"},{"key":"2025121508165668000_10.7.e039519.33","first-page":"1","article-title":"Intravenous vitamin C administered as adjunctive therapy for recurrent acute respiratory distress syndrome","volume":"2016","author":"Bharara","year":"2016","journal-title":"Case Rep Crit Care"},{"key":"2025121508165668000_10.7.e039519.34","first-page":"541","article-title":"Antiviral effects of ascorbic and dehydroascorbic acids in vitro","volume":"22","author":"Furuya","year":"2008","journal-title":"Int J Mol Med"},{"key":"2025121508165668000_10.7.e039519.35","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-140-7-200404060-00010"},{"key":"2025121508165668000_10.7.e039519.36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40560-020-0432-y","article-title":"Vitamin C may reduce the duration of mechanical ventilation in critically ill patients: a meta-regression analysis","volume":"8","author":"Hemil\u00e4","year":"2020","journal-title":"J Intensive Care"},{"key":"2025121508165668000_10.7.e039519.37","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-32"},{"key":"2025121508165668000_10.7.e039519.38","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/jama.2019.11825","article-title":"Effect of vitamin C infusion on organ failure and biomarkers of inflammation and vascular injury in patients with sepsis and severe acute respiratory failure: the CITRIS-ALI randomized clinical trial","volume":"322","author":"Fowler","year":"2019","journal-title":"JAMA"},{"key":"2025121508165668000_10.7.e039519.39","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5492\/wjccm.v6.i1.85","article-title":"Intravenous vitamin C as adjunctive therapy for enterovirus\/rhinovirus induced acute respiratory distress syndrome","volume":"6","author":"Fowler Iii","year":"2017","journal-title":"World J Crit Care Med"},{"key":"2025121508165668000_10.7.e039519.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1975.tb29311.x"},{"key":"2025121508165668000_10.7.e039519.41","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1097\/BCR.0000000000000233","article-title":"Oxalate nephropathy after continuous infusion of high-dose vitamin C as an adjunct to burn resuscitation","volume":"37","author":"Buehner","year":"2016","journal-title":"J Burn Care Res"},{"key":"2025121508165668000_10.7.e039519.42","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-82-6-810_1","article-title":"Letter: ascorbic acid-induced hemolysis in G-6-PD deficiency","volume":"82","author":"Campbell","year":"1975","journal-title":"Ann Intern Med"},{"key":"2025121508165668000_10.7.e039519.43","first-page":"756","article-title":"Acute kidney injury following high-dose vitamin C treatment","volume":"116","author":"Andres","year":"2019","journal-title":"Dtsch Arztebl Int"},{"key":"2025121508165668000_10.7.e039519.44","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-231504","article-title":"Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency","volume":"12","author":"Fijen","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2025121508165668000_10.7.e039519.45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011414"},{"key":"2025121508165668000_10.7.e039519.46","first-page":"329","article-title":"Safety of vitamin C in sepsis: a neglected topic","volume":"25","author":"Khoshnam-Rad","year":"2019","journal-title":"Curr Opin Crit Care"},{"key":"2025121508165668000_10.7.e039519.47","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-158-3-201302050-00583"},{"key":"2025121508165668000_10.7.e039519.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1103502"},{"key":"2025121508165668000_10.7.e039519.49","unstructured":"The Guideline for COVID-19 (version 5) issued by the National health Commission of the people's Republic of China, 2020. Available: http:\/\/www.nhc.gov.cn\/yzygj\/s7653p\/202002\/3b09b894ac9b4204a79db5b8912d4440.shtml [Accessed 5 Feb 2020]."},{"key":"2025121508165668000_10.7.e039519.50","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.12173"},{"key":"2025121508165668000_10.7.e039519.51","unstructured":"The good clinical practice (GCP) issued by the National medical administration of the people's Republic of China, 2003. Available: http:\/\/www.gov.cn\/gongbao\/content\/2004\/content_63115.htm [Accessed 6 Aug 2003]."},{"key":"2025121508165668000_10.7.e039519.52","first-page":"287","article-title":"Intravenous ascorbic acid: protocol for its application and use","volume":"22","author":"Riordan","year":"2003","journal-title":"P R Health Sci J"},{"key":"2025121508165668000_10.7.e039519.53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2012.5669"},{"key":"2025121508165668000_10.7.e039519.54","doi-asserted-by":"publisher","DOI":"10.1159\/000339789"},{"key":"2025121508165668000_10.7.e039519.55","unstructured":"Coronavirus disease 2019 (COVID-19) situation report \u2013 23: World Health organization, 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/situation-reports [Accessed 12 Feb 2020]."},{"key":"2025121508165668000_10.7.e039519.56","doi-asserted-by":"crossref","DOI":"10.1186\/s13613-019-0532-9","article-title":"Effects of different ascorbic acid doses on the mortality of critically ill patients: a meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"Ann Intensive Care"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2020-039519","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T16:17:07Z","timestamp":1765815427000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2020-039519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":56,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,8]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bmjopen-2020-039519"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2020-039519","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}